Correlation Between Konica Minolta and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Konica Minolta and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Konica Minolta and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Konica Minolta and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Konica Minolta and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Konica Minolta with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Konica Minolta and Recursion Pharmaceuticals.
Diversification Opportunities for Konica Minolta and Recursion Pharmaceuticals
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Konica and Recursion is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Konica Minolta and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Konica Minolta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Konica Minolta are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Konica Minolta i.e., Konica Minolta and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Konica Minolta and Recursion Pharmaceuticals
Assuming the 90 days horizon Konica Minolta is expected to generate 2.76 times less return on investment than Recursion Pharmaceuticals. But when comparing it to its historical volatility, Konica Minolta is 2.57 times less risky than Recursion Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 751.00 in Recursion Pharmaceuticals on September 13, 2024 and sell it today you would lose (15.00) from holding Recursion Pharmaceuticals or give up 2.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Konica Minolta vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Konica Minolta |
| Recursion Pharmaceuticals |
Konica Minolta and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Konica Minolta and Recursion Pharmaceuticals
The main advantage of trading using opposite Konica Minolta and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Konica Minolta position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Konica Minolta vs. Recursion Pharmaceuticals | Konica Minolta vs. Butterfly Network | Konica Minolta vs. SoundHound AI | Konica Minolta vs. IONQ Inc |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |